The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Liraglutide promotes improvements in objective measures of cognitive dysfunction in individuals with mood disorders: A pilot, open-label study
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Vos, T., Flaxman, A. D., Naghavi, M., Lozano, R., Michaud, C., Ezzati, M., Shibuya, K., Salomon, J. A., Abdalla, S., Aboyans, V., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61729-2 · Cited by 8,291
Use and Abuse of HOMA Modeling
Wallace, T. M., Levy, J. C., & Matthews, D. R. (2004) · Diabetes Care · doi:10.2337/diacare.27.6.1487 · Cited by 5,114
Snyder, H. R. (2013) · Psychological Bulletin · doi:10.1037/a0028727 · Cited by 1,667
Raison, C. L., Rutherford, R. E., Woolwine, B. J., Shuo, C., Schettler, P., Drake, D. F., Haroon, E., & Miller, A. H. (2013) · JAMA Psychiatry · doi:10.1001/2013.jamapsychiatry.4 · Cited by 1,617
Glucagon-like peptide-1 receptor is involved in learning and neuroprotection
During, M. J., Cao, L., Zuzga, D. S., Francis, J. S., Fitzsimons, H. L., Jiao, X., Bland, R. J., Klugmann, M., Banks, W. A., Drucker, D. J., et al. (2003) · Nature Medicine · doi:10.1038/nm919 · Cited by 851
McIntyre, R. S., Cha, D. S., Soczynska, J. K., Woldeyohannes, H. O., Gallaugher, L. A., Kudlow, P., Alsuwaidan, M., & Baskaran, A. (2013) · Depression and Anxiety · doi:10.1002/da.22063 · Cited by 765
Self-citationComorbidities and Mortality in Bipolar Disorder: A Swedish National Cohort Study
Crump, C., Sundquist, K., Winkleby, M. A., & Sundquist, J. (2013) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2013.1394 · Cited by 677
Interactions of Glucagon-Like Peptide-1 (GLP-1) with the Blood-Brain Barrier
Kastin, A. J., Akerstrom, V., & Pan, W. (2002) · Journal of Molecular Neuroscience · doi:10.1385/jmn:18:1-2:07 · Cited by 480
Gejl, M., Gjedde, A., Egefjord, L., Møller, A., Hansen, S. B., Vang, K., Rodell, A., Brændgaard, H., Gottrup, H., Schacht, A., et al. (2016) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2016.00108 · Cited by 480
McIntyre, R. S., Lophaven, S., & Olsen, C. K. (2014) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145714000546 · Cited by 433
Self-citation
Research works printed but not linked: 58
- Alvarez, 2005, The expression of GLP-1 receptor mRNA and protein allows the effect of GLP-1 on glucose metabolism in the human hypothalamus and brainstem, J. Neurochem., 92, 798, 10.1111/j.1471-4159.2004.02914.x · DOI · Paper page
- Bomfim, 2012, An anti-diabetes agent protects the mouse brain from defective insulin signaling caused by Alzheimer’s disease- associated Abeta oligomers, J. Clin. Investig., 122, 1339, 10.1172/JCI57256 · DOI · Paper page
- Bourne, 2013, Neuropsychological testing of cognitive impairment in euthymic bipolar disorder: an individual patient data meta-analysis, Acta Psychiatr. Scand., 128, 149, 10.1111/acps.12133 · DOI · Paper page
- Bove, 2013, Metabolic and endocrine correlates of cognitive function in healthy young women, Obesity, 21, 1343, 10.1002/oby.20212 · DOI
- Cabou, 2008, Brain glucagon-like peptide-1 regulates arterial blood flow, heart rate, and insulin sensitivity, Diabetes, 57, 2577, 10.2337/db08-0121 · DOI
- Calkin, 2015, Insulin resistance and outcome in bipolar disorder, Br. J. Psychiatry, 206, 52, 10.1192/bjp.bp.114.152850 · DOI · Paper page
- DanieleG., IozzoP., Molina-CarrionM., LancasterJ., CiociaroD., CersosimoE., TripathyD., TriplittC., FoxP., MusiN., DeFronzoR., GastaldelliA., 2015. . Exenatide Regulates Cerebral Glucose Metabolism in Brain Areas Associated with Glucose Homeostasis and Reward System. Diabetes. · DOI
- Darsalia, 2012, Glucagon-like peptide-1 receptor activation reduces ischaemic brain damage following stroke in Type 2 diabetic rats, Clin. Sci. (Lond.), 122, 473, 10.1042/CS20110374 · DOI
- Depp, 2012, Meta-analysis of the association between cognitive abilities and everyday functioning in bipolar disorder, Bipolar Disord., 14, 217, 10.1111/j.1399-5618.2012.01011.x · DOI · Paper page
- Dias, 2012, Pharmacological approaches in bipolar disorders and the impact on cognition: a critical overview, Acta Psychiatr. Scand., 126, 315, 10.1111/j.1600-0447.2012.01910.x · DOI · Paper page
- Drucker, 2003, Enhancing incretin action for the treatment of type 2 diabetes, Diabetes Care, 26, 2929, 10.2337/diacare.26.10.2929 · DOI · Paper page
- Engler, 2006, Two-year follow-up of amyloid deposition in patients with Alzheimer’s disease, Brain, 129, 2856, 10.1093/brain/awl178 · DOI · Paper page
- Gault, 2008, GLP-1 agonists facilitate hippocampal LTP and reverse the impairment of LTP induced by beta-amyloid, Eur. J. Pharm., 587, 112, 10.1016/j.ejphar.2008.03.025 · DOI
- Geijselaers, S.L., Sep, S.J., Stehouwer, C.D., Biessels, G.J., 2014. Glucose regulation, cognition, and brain MRI in type 2 diabetes: a systematic review. Lancet Diabetes Endocrinol. · DOI · Paper page
- Gejl, 2012, Glucagon-like peptide-1 decreases intracerebral glucose content by activating hexokinase and changing glucose clearance during hyperglycemia, J. Cereb. Blood Flow. Metab., 32, 2146, 10.1038/jcbfm.2012.118 · DOI
- Gengler, 2012, Val(8)GLP-1 rescues synaptic plasticity and reduces dense core plaques in APP/PS1 mice, Neurobiol. Aging, 33, 265, 10.1016/j.neurobiolaging.2010.02.014 · DOI · Paper page
- Goldstein, 2013, Obesity and the three-year longitudinal course of bipolar disorder, Bipolar Disord., 15, 284, 10.1111/bdi.12035 · DOI
- Gomes, 2013, Cardiovascular risk factors in outpatients with bipolar disorder: a report from the Brazilian Research Network in Bipolar Disorder, Rev. Bras. Psiquiatr, 35, 126, 10.1590/1516-4446-2011-0768 · DOI
- Hajek, 2015, Type 2 diabetes mellitus: a potentially modifiable risk factor for neurochemical brain changes in bipolar disorders, Biol. Psychiatry, 77, 295, 10.1016/j.biopsych.2013.11.007 · DOI
- Hajek, 2014, Insulin resistance, diabetes mellitus, and brain structure in bipolar disorders, Neuropsychopharmacology, 39, 2910, 10.1038/npp.2014.148 · DOI
- Handley, T.E., Ventura, A.D., Browne, J.L., Rich, J., Attia, J.R., Reddy, P., Pouwer, F., Speight, J., 2015. Suicidal ideation reported by adults with Type 1 or Type 2 diabetes: results from Diabetes MILES-Australia. Diabet. Med. · DOI
- Heni, 2012, Nasal insulin changes peripheral insulin sensitivity simultaneously with altered activity in homeostatic and reward-related human brain regions, Diabetologia, 55, 1773, 10.1007/s00125-012-2528-y · DOI
- Iwai, 2009, The influences of juvenile diabetes on memory and hippocampal plasticity in rats: improving effects of glucagon-like peptide-1, Neurosci. Res, 64, 67, 10.1016/j.neures.2009.01.013 · DOI
- Karlamangla, 2014, Biological correlates of adult cognition: midlife in the United States (MIDUS), Neurobiol. Aging, 35, 387, 10.1016/j.neurobiolaging.2013.07.028 · DOI
- Katsurada, 2014, Endogenous GLP-1 acts on paraventricular nucleus to suppress feeding: projection from nucleus tractus solitarius and activation of corticotropin-releasing hormone, nesfatin-1 and oxytocin neurons, Biochem. Biophys. Res. Commun., 451, 276, 10.1016/j.bbrc.2014.07.116 · DOI
- Kessler, 2005, Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication, Arch. Gen. Psychiatry, 62, 593, 10.1001/archpsyc.62.6.593 · DOI · Paper page
- Kleine-Budde, 2014, Cost of illness for bipolar disorder: a systematic review of the economic burden, Bipolar Disord., 16, 337, 10.1111/bdi.12165 · DOI
- Levy, 1998, Correct homeostasis model assessment (HOMA) evaluation uses the computer program, Diabetes Care, 21, 2191, 10.2337/diacare.21.12.2191 · DOI · Paper page
- Long-Smith, 2013, The diabetes drug liraglutide ameliorates aberrant insulin receptor localisation and signalling in parallel with decreasing both amyloid-beta plaque and glial pathology in a mouse model of Alzheimer’s disease, Neuromolecular Med., 15, 102, 10.1007/s12017-012-8199-5 · DOI
- Malloy-Diniz, 2009, Suicide behavior and neuropsychological assessment of type I bipolar patients, J. Affect Disord., 112, 231, 10.1016/j.jad.2008.03.019 · DOI · Paper page
- Mansur, 2015, Is there a “metabolic-mood syndrome”? A review of the relationship between obesity and mood disorders, Neurosci. Biobehav. Rev., 52, 89, 10.1016/j.neubiorev.2014.12.017 · DOI · Paper page
- Mansur, 2016, Adipokines, metabolic dysfunction and illness course in bipolar disorder, J. Psychiatr. Res., 74, 63, 10.1016/j.jpsychires.2015.12.003 · DOI
- Mansur, 2016, Bipolar disorder course, impaired glucose metabolism and antioxidant enzymes activities: a preliminary report, J. Psychiatr. Res., 80, 38, 10.1016/j.jpsychires.2016.05.014 · DOI
- Mansur, 2016, Brain-derived neurotrophic factor, impaired glucose metabolism, and bipolar disorder course, Bipolar Disord., 18, 373, 10.1111/bdi.12399 · DOI
- Martino, 2008, Heterogeneity in cognitive functioning among patients with bipolar disorder, J. Affect Disord., 109, 149, 10.1016/j.jad.2007.12.232 · DOI · Paper page
- McClean, 2014, Liraglutide can reverse memory impairment, synaptic loss and reduce plaque load in aged APP/PS1 mice, a model of Alzheimer’s disease, Neuropharmacology, 76, 57, 10.1016/j.neuropharm.2013.08.005 · DOI · Paper page
- McClean, 2011, The diabetes drug liraglutide prevents degenerative processes in a mouse model of Alzheimer’s disease, J. Neurosci., 31, 6587, 10.1523/JNEUROSCI.0529-11.2011 · DOI · Paper page
- McIntyre, 2010, Bipolar disorder and metabolic syndrome: an international perspective, J. Affect. Disord., 126, 366, 10.1016/j.jad.2010.04.012 · DOI · Paper page
- McIntyre, 2013, The neuroprotective effects of GLP-1: possible treatments for cognitive deficits in individuals with mood disorders, Behav. Brain Res., 237, 164, 10.1016/j.bbr.2012.09.021 · DOI · Paper page
- Mosconi, 2005, Brain glucose metabolism in the early and specific diagnosis of Alzheimer’s disease. FDG-PET studies in MCI and AD, Eur. J. Nucl. Med. Mol. Imaging, 32, 486, 10.1007/s00259-005-1762-7 · DOI · Paper page
- Naiberg, 2016, Elevated triglycerides are associated with decreased executive function among adolescents with bipolar disorder, Acta Psychiatr. Scand., 134, 241, 10.1111/acps.12603 · DOI
- Parkinson, 2009, Differential patterns of neuronal activation in the brainstem and hypothalamus following peripheral injection of GLP-1, oxyntomodulin and lithium chloride in mice detected by manganese-enhanced magnetic resonance imaging (MEMRI), Neuroimage, 44, 1022, 10.1016/j.neuroimage.2008.09.047 · DOI
- Perugi, 2015, General medical conditions in 347 bipolar disorder patients: clinical correlates of metabolic and autoimmune-allergic diseases, J. Affect. Disord., 170, 95, 10.1016/j.jad.2014.08.052 · DOI
- Porter, 2010, Four weeks administration of Liraglutide improves memory and learning as well as glycaemic control in mice with high fat dietary-induced obesity and insulin resistance, Diabetes Obes. Metab., 12, 891, 10.1111/j.1463-1326.2010.01259.x · DOI
- Ram, 2014, Hypertriglyceridaemic waist phenotype as a simple predictive marker of incident diabetes in Asian-Indian men with prediabetes, Diabet. Med., 31, 1542, 10.1111/dme.12517 · DOI
- Richard, 2014, GLP-1 receptor stimulation of the lateral parabrachial nucleus reduces food intake: neuroanatomical, electrophysiological, and behavioral evidence, Endocrinology, 155, 4356, 10.1210/en.2014-1248 · DOI
- Rinaman, 1999, Interoceptive stress activates glucagon-like peptide-1 neurons that project to the hypothalamus, Am. J. Physiol., 277, R582
- Ruzickova, 2003, Clinical features of bipolar disorder with and without comorbid diabetes mellitus, Can. J. Psychiatry, 48, 458, 10.1177/070674370304800705 · DOI
- Schlogl, 2013, Exenatide-induced reduction in energy intake is associated with increase in hypothalamic connectivity, Diabetes Care, 36, 1933, 10.2337/dc12-1925 · DOI
- Shapiro, J., Mindra, S., Timmins, V., Swampillai, B., Scavone, A., Collinger, K., Collins, J., Goldstein, B.I., 2016. Controlled study of obesity among adolescents with bipolar disorder. J. Child Adolesc. Psychopharmacol. · DOI
- Shelton, 2015, Association of obesity and inflammatory marker levels on treatment outcome: results from a double-blind, randomized study of adjunctive l-methylfolate calcium in patients with MDD who are inadequate responders to SSRIs, J. Clin. Psychiatry, 76, 1635, 10.4088/JCP.14m09587 · DOI
- Snitz, 2013, Cognitive trajectories associated with beta-amyloid deposition in the oldest-old without dementia, Neurology, 80, 1378, 10.1212/WNL.0b013e31828c2fc8 · DOI
- Talbot, 2014, The nature, significance, and glucagon-like peptide-1 analog treatment of brain insulin resistance in Alzheimer’s disease, Alzheimers Dement, 10, S12, 10.1016/j.jalz.2013.12.007 · DOI
- Teramoto, 2011, Exendin-4, a glucagon-like peptide-1 receptor agonist, provides neuroprotection in mice transient focal cerebral ischemia, J. Cereb. Blood Flow. Metab., 31, 1696, 10.1038/jcbfm.2011.51 · DOI · Paper page
- van Bloemendaal, 2014, GLP-1 receptor activation modulates appetite- and reward-related brain areas in humans, Diabetes, 63, 4186, 10.2337/db14-0849 · DOI · Paper page
- Vancampfort, 2013, Metabolic syndrome and metabolic abnormalities in bipolar disorder: a meta-analysis of prevalence rates and moderators, Am. J. Psychiatry, 170, 265, 10.1176/appi.ajp.2012.12050620 · DOI · Paper page
- Wolinsky, 2013, A randomized controlled trial of cognitive training using a visual speed of processing intervention in middle aged and older adults, PLoS One, 8, e61624, 10.1371/journal.pone.0061624 · DOI · Paper page
- Yogi-Morren, 2014, Duration of type 2 diabetes and very low density lipoprotein levels are associated with cognitive dysfunction in metabolic syndrome, Cardiovasc. Psychiatry Neurol., 2014, 656341, 10.1155/2014/656341 · DOI
Cited by
McIntyre, R. S., Berk, M., Brietzke, E., Goldstein, B. I., López-Jaramillo, C., Kessing, L. V., Malhi, G. S., Nierenberg, A. A., Rosenblat, J. D., Majeed, A., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)31544-0 · Cited by 1,047
Self-citationAnxiety, depression, and the microbiome: A role for gut peptides
Lach, G., Schellekens, H., Dinan, T. G., & Cryan, J. F. (2018) · Neurotherapeutics · doi:10.1007/s13311-017-0585-0 · Cited by 573
Cognitive Impairment in Major Depressive Disorder
Pan, Z., Park, C., Brietzke, E., Zuckerman, H., Rong, C., Mansur, R. B., Fus, D., Subramaniapillai, M., Lee, Y., & McIntyre, R. S. (2019) · CNS Spectrums · doi:10.1017/s1092852918001207 · Cited by 320
Self-citationCukierman-Yaffe, T., Gerstein, H. C., Colhoun, H. M., Diaz, R., García-Pérez, L.-E., Lakshmanan, M., Bethel, A., Xavier, D., Probstfield, J., Riddle, M. C., et al. (2020) · The Lancet Neurology · doi:10.1016/s1474-4422(20)30173-3 · Cited by 300
Reich, N., & Hölscher, C. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.970925 · Cited by 248
Metadata
- Authors
- Mansur, R. B., Ahmed, J., Cha, D. S., Woldeyohannes, H. O., Subramaniapillai, M., Lovshin, J., Lee, J. G., Lee, J.-H., Brietzke, E., Reininghaus, E. Z., Sim, K., Vinberg, M., Rasgon, N., Hajek, T., & McIntyre, R. S.
- Venue
- Journal of Affective Disorders
- Publisher
- Elsevier BV
- Published
- 2017-01
- Volume
- 207
- Pages
- 114-120
- ISSN
- 0165-0327 (ISSN-L)
- OpenAlex
- W2527740737
- Cited by
- 164
- References
- 27
- FWCI
- 11.35
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Liraglutide promotes improvements in objective measures of cognitive dysfunction in individuals with mood disorders: A pilot, open-label study. https://app.cochat.ai/papers/10.1016/j.jad.2016.09.056
- The paper
- Mansur, R. B., Ahmed, J., Cha, D. S., Woldeyohannes, H. O., Subramaniapillai, M., Lovshin, J., Lee, J. G., Lee, J.-H., Brietzke, E., Reininghaus, E. Z., Sim, K., Vinberg, M., Rasgon, N., Hajek, T., & McIntyre, R. S. (2017). Liraglutide promotes improvements in objective measures of cognitive dysfunction in individuals with mood disorders: A pilot, open-label study. Journal of Affective Disorders. https://doi.org/10.1016/j.jad.2016.09.056
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.